BDBM50291951 (R)-2-(2-Amino-thiazol-4-ylmethyl)-N*1*-((1S,2R,3S)-1-cyclohexylmethyl-2,3-dihydroxy-5-methyl-hexyl)-N*4*-[(methyl-{2-[methyl-(morpholine-4-carbonyl)-amino]-ethyl}-carbamoyl)-methyl]-N*4*-((S)-1-phenyl-ethyl)-succinamide::CHEMBL430781
SMILES: CC(C)C[C@H](O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@@H](CC(=O)N(CC(=O)N(C)CCN(C)C(=O)N1CCOCC1)[C@@H](C)c1ccccc1)Cc1csc(N)n1
InChI Key: InChIKey=TYLSXDULXDNDBD-NRGLOYHDSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Renin (Homo sapiens (Human)) | BDBM50291951 ((R)-2-(2-Amino-thiazol-4-ylmethyl)-N*1*-((1S,2R,3S...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | n/a | 0.00133 | 5.43E+6 | n/a | n/a |
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL | Assay Description Component acylation rate constant by the compound against Renin was determined | J Med Chem 38: 1751-61 (1995) BindingDB Entry DOI: 10.7270/Q2K35SQR | |||||||||||
More data for this Ligand-Target Pair |